Munafa Stock Market Course + Intraday & FNO calls 
Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Cue Biopharma (CUE)
Technical Analysis Report for NASDAQ stock CUE Cue Biopharma. Dated: 06 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma
Cue Biopharma Opened at 0.30 and Closed at: 0.30, which is 3.33% of previous session's close. It moved within a range of 0.29 and 0.30
The session was a Neutral session with an average volume of 599100, which is 60.77% of previous session's volumes.
Support for tomorrow is 0.3 and resistance for tomorrow is 0.31
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.29, 0.29 resistance for tomorrow's hourly charts is 0.3, 0.31
10 Day SMA for Cue Biopharma (CUE) is 0.29 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Cue Biopharma (CUE) is 0.3 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Cue Biopharma (CUE) is 0.32 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.47 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Cue Biopharma is 0.61 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Cue Biopharma is at 0.3 and 200 DMA is at 0.61, while 50 DMA and 100 DMA are at 0.32 and 0.47 respectively
Cue Biopharma (CUE) moving average of 20 SMA is at 0.3 and 20 EMA is at 0.33
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Mar | 0.30 | 0.3 | 0.33 |
| 05 Thu Mar | 0.29 | 0.3 | 0.33 |
| 04 Wed Mar | 0.30 | 0.3 | 0.33 |
| 03 Tue Mar | 0.30 | 0.3 | 0.33 |
| 02 Mon Mar | 0.28 | 0.3 | 0.33 |
| 27 Fri Feb | 0.28 | 0.3 | 0.33 |
Cue Biopharma (CUE) moving average of 50 SMA is at 0.32 and 50 EMA is at 0.4
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Mar | 0.30 | 0.32 | 0.4 |
| 05 Thu Mar | 0.29 | 0.32 | 0.4 |
| 04 Wed Mar | 0.30 | 0.32 | 0.4 |
| 03 Tue Mar | 0.30 | 0.32 | 0.4 |
| 02 Mon Mar | 0.28 | 0.32 | 0.4 |
| 27 Fri Feb | 0.28 | 0.32 | 0.4 |
Cue Biopharma (CUE) moving average of 100 SMA is at 0.47 and 100 EMA is at 0.53
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Mar | 0.30 | 0.47 | 0.53 |
| 05 Thu Mar | 0.29 | 0.47 | 0.53 |
| 04 Wed Mar | 0.30 | 0.48 | 0.53 |
| 03 Tue Mar | 0.30 | 0.49 | 0.53 |
| 02 Mon Mar | 0.28 | 0.49 | 0.53 |
| 27 Fri Feb | 0.28 | 0.5 | 0.53 |
Cue Biopharma (CUE) moving average of 200 SMA is at 0.61 and 200 EMA is at 0.78
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Mar | 0.30 | 0.61 | 0.78 |
| 05 Thu Mar | 0.29 | 0.61 | 0.78 |
| 04 Wed Mar | 0.30 | 0.61 | 0.78 |
| 03 Tue Mar | 0.30 | 0.62 | 0.78 |
| 02 Mon Mar | 0.28 | 0.62 | 0.78 |
| 27 Fri Feb | 0.28 | 0.62 | 0.78 |
Cue Biopharma has performed better than Tenax Therapeutics in short term. Holding Cue Biopharma could be a better choice for now!
Tactile Systems has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Tactile Systems, about 11.78% more returns!
Replimune Group has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Replimune Group, about 9.72% more returns!
Cue Biopharma has performed better than Pulmatrix Inc in short term. Holding Cue Biopharma could be a better choice for now!
Cue Biopharma has performed better than Neurocrine Biosciences in short term. Holding Cue Biopharma could be a better choice for now!
Autolus Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 9.67% more returns!
Electrocore Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Electrocore Inc, about 34.29% more returns!
Cue Biopharma has performed better than Heron Therapeutics in short term. Holding Cue Biopharma could be a better choice for now!
Immuron has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Immuron, about 23.58% more returns!
Cue Biopharma has performed better than Incyte Corporation in short term. Holding Cue Biopharma could be a better choice for now!
Cue Biopharma has performed better than Kala Pharmaceuticals in short term. Holding Cue Biopharma could be a better choice for now!
Cue Biopharma Technical analysis of indicators
Price action analysis of Cue Biopharma (CUE) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Cue Biopharma in short term and the sell signal is strong.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Cue Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.29 and Cue Biopharma CUE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.
Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CUE Experts View which covers a lot of information including buying and selling signals
CUE future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
